{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:12:17Z","timestamp":1781010737616,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.atherosclerosis.2009.01.039","type":"journal-article","created":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T04:10:48Z","timestamp":1234066248000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice"],"prefix":"10.1016","volume":"206","author":[{"given":"Sachiko","family":"Sakurabayashi-Kitade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Aoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kasanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.01.039_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02158515","article-title":"Constitution of aldosterone, a new mineralocorticoid","volume":"10","author":"Simpson","year":"1954","journal-title":"Experientia"},{"key":"10.1016\/j.atherosclerosis.2009.01.039_bib2","first-page":"522","article-title":"Control of adrenal secretion of electrolyte-active steroids; adrenal stimulation by cross-circulation experiments in conscious sheep","volume":"5151","author":"Denton","year":"1959","journal-title":"Brookhaven Symp Biol"},{"key":"10.1016\/j.atherosclerosis.2009.01.039_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(59)91584-3","article-title":"Clinical and metabolic effects of aldosterone antagonism","volume":"2","author":"Slater","year":"1959","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.01.039_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI103903","article-title":"Evidence that a humoral agent stimulates the adrenal cortex to secrete aldosterone in experimental secondary hyperaldosteronism","volume":"38","author":"Yankopoulos","year":"1959","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0033-0620(74)90037-1","article-title":"Renin and aldosterone and the pathogenesis of hypertensive vascular damage","volume":"17","author":"Gavras","year":"1974","journal-title":"Prog Cardiovasc Dis"},{"issue":"2A","key":"10.1016\/j.atherosclerosis.2009.01.039_bib6","doi-asserted-by":"crossref","first-page":"11A","DOI":"10.1016\/S0002-9149(01)02322-0","article-title":"Angiotensin II and trials of cardiovascular outcomes","volume":"89","author":"Sleight","year":"2002","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.01.039_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"issue":"9215","key":"10.1016\/j.atherosclerosis.2009.01.039_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014The Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2009.01.039_bib9","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease","volume":"21","author":"Hene","year":"1982","journal-title":"Kidney Int"},{"issue":"12 Pt 1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0895-7061(97)00301-4","article-title":"Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension","volume":"10","author":"Blacher","year":"1997","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.01.039_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"issue":"34\u201335","key":"10.1016\/j.atherosclerosis.2009.01.039_bib13","first-page":"987","article-title":"The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study","volume":"124","author":"Schwinger","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.01.039_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mhj.2002.120775","article-title":"Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)","volume":"143","author":"Spertus","year":"2002","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.01.039_bib15","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2009.01.039_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.01.039_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.01.039_bib18","doi-asserted-by":"crossref","first-page":"pe124","DOI":"10.1161\/01.RES.0000102404.81461.25","article-title":"Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine\u2013immune interface","volume":"93","author":"Ahokas","year":"2003","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.01.039_bib19","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00113.2003","article-title":"Aldosteronism: an immunostimulatory state precedes proinflammatory\/fibrogenic cardiac phenotype","volume":"285","author":"Gerling","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2009.01.039_bib20","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1016\/S0021-9258(19)50246-0","article-title":"Chimeric renin\u2013angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes","volume":"268","author":"Fukamizu","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.01.039_bib21","first-page":"835","article-title":"Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin\u2013angiotensin system","volume":"76","author":"Sugiyama","year":"1997","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.01.039_bib22","first-page":"1059","article-title":"Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II","volume":"78","author":"Nishijo","year":"1998","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.01.039_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1538\/expanim.48.203","article-title":"Vascular remodeling in hypertensive transgenic mice","volume":"48","author":"Nishijo","year":"1999","journal-title":"Exp Anim"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2009.01.039_bib25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.25.6.1252","article-title":"Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats","volume":"25","author":"Kim","year":"1995","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.01.039_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.HYP.0000138688.78906.6b","article-title":"Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling","volume":"44","author":"Zhao","year":"2004","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.01.039_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1358\/mf.2003.25.7.778094","article-title":"Role of intracardiac renin\u2013angiotensin\u2013aldosterone system in extracellular matrix remodeling","volume":"25","author":"Lijnen","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2009.01.039_bib28","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.01.039_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","article-title":"Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"36","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.01.039_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.RES.0000049100.22673.F6","article-title":"DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease","volume":"92","author":"Campos","year":"2003","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.01.039_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1291\/hypres.31.987","article-title":"Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq\/11, Ras, ERK, Src and Ets-1","volume":"31","author":"Abe","year":"2008","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.01.039_bib33","doi-asserted-by":"crossref","first-page":"H2597","DOI":"10.1152\/ajpheart.00299.2007","article-title":"Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice","volume":"293","author":"Louis","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.01.039_bib34","first-page":"S12","article-title":"Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes","volume":"22","author":"Uehara","year":"1995","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.01.039_bib35","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1248\/bpb.29.1756","article-title":"Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats","volume":"29","author":"Kubota","year":"2006","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.01.039_bib36","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ajh.2008.301","article-title":"Validation of volume-pressure recording tail-cuff blood pressure measurements","volume":"21","author":"Feng","year":"2008","journal-title":"Am J Hypertens"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:29:54Z","timestamp":1758155394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0021915009000860"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.01.039","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}